Cargando…
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
BACKGROUND: To evaluate off-label and off-NCCN guidelines uses of antineoplastic drugs in a major Chinese hospital. METHODS: Totally 1122 patients were selected from July to December 2011. Then, the off-label and off-NCCN guidelines uses of antineoplastic drugs were analyzed. RESULTS: In 798 of 1122...
Autores principales: | WANG, Weilan, ZHU, Man, GUO, Daihong, CHEN, Chao, WANG, Dongxiao, PEI, Fei, MA, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684455/ https://www.ncbi.nlm.nih.gov/pubmed/23802104 |
Ejemplares similares
-
Antineoplastics: Pancytopenia and off-label use: case report
Publicado: (2020) -
Guideline for the management of pediatric off-label use of drugs in China (2021)
por: Meng, Min, et al.
Publicado: (2022) -
Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
por: Li, Guangyao, et al.
Publicado: (2022) -
Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022) -
Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)